Dow Jones

40,003.59

0.34%

Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Clementia Pharmaceuticals Inc. (CMTA)
Clementia Pharmaceuticals Inc. (CMTA) Noticias

CMTA

Clementia Pharmaceuticals Inc. (CMTA)

Clementia Pharmaceuticals Inc.

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CMTA

1 2 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
15/08/2019	07:30	GlobeNewswire Inc.	Accomplished Financial Executive, Steve Forte, Joins Profound Medical’s Board	NASDAQ:CMTA	Clementia Pharmaceuticals Inc.
29/04/2019	07:28	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:CMTA	Clementia Pharmaceuticals Inc.
19/04/2019	05:01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:CMTA	Clementia Pharmaceuticals Inc.
18/04/2019	08:11	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	NASDAQ:CMTA	Clementia Pharmaceuticals Inc.
18/04/2019	07:05	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:CMTA	Clementia Pharmaceuticals Inc.
18/04/2019	07:04	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:CMTA	Clementia Pharmaceuticals Inc.
18/04/2019	07:02	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CMTA	Clementia Pharmaceuticals Inc.
11/04/2019	11:00	GlobeNewswire Inc.	Clementia Pharmaceuticals Inc. Announces Receipt of Final Court Approval for Plan of Arrangement With Ipsen S.A.	NASDAQ:CMTA	Clementia Pharmaceuticals Inc.
09/04/2019	11:29	GlobeNewswire Inc.	Clementia Pharmaceuticals Inc. Shareholders Approve Plan of Arrangement With Ipsen S.A.	NASDAQ:CMTA	Clementia Pharmaceuticals Inc.
29/03/2019	16:09	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:CMTA	Clementia Pharmaceuticals Inc.
13/03/2019	06:24	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:CMTA	Clementia Pharmaceuticals Inc.
07/03/2019	13:59	PR Newswire (US)	Clementia Pharmaceuticals Inc. Obtains Interim Order for Proposed Transaction With Ipsen S.A. and Enters Into Support and Vot...	NASDAQ:CMTA	Clementia Pharmaceuticals Inc.
07/03/2019	12:25	PR Newswire (Canada)	Clementia Pharmaceutiques Inc. obtient une ordonnance provisoire pour la transaction proposée avec Ipsen S.A. et conclut des...	NASDAQ:CMTA	Clementia Pharmaceuticals Inc.
07/03/2019	12:00	PR Newswire (US)	Clementia Pharmaceuticals Inc. obtains interim order for proposed transaction with Ipsen S.A. and enters into support and vot...	NASDAQ:CMTA	Clementia Pharmaceuticals Inc.
01/03/2019	15:03	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:CMTA	Clementia Pharmaceuticals Inc.
01/03/2019	13:15	PR Newswire (US)	SHAREHOLDER ALERT: WeissLaw LLP Investigates Clementia Pharmaceuticals, Inc.	NASDAQ:CMTA	Clementia Pharmaceuticals Inc.
26/02/2019	05:30	GlobeNewswire Inc.	Clementia Announces Cancellation of Fourth Quarter and Year-End 2018 Financial Results and Conference Call	NASDAQ:CMTA	Clementia Pharmaceuticals Inc.
25/02/2019	00:00	Business Wire	Ipsen to Acquire Clementia Pharmaceuticals to Significantly Boost Rare Disease Portfolio	NASDAQ:CMTA	Clementia Pharmaceuticals Inc.
25/02/2019	00:00	Business Wire	Ipsen annonce l’acquisition de Clementia Pharmaceuticals et renforce son portefeuille dans les Maladies Rares	NASDAQ:CMTA	Clementia Pharmaceuticals Inc.
20/02/2019	05:30	GlobeNewswire Inc.	Clementia Announces Date of Fourth Quarter and Full Year 2018 Results and Presentation at 8th Annual SVB Leerink Global Healt...	NASDAQ:CMTA	Clementia Pharmaceuticals Inc.
13/02/2019	15:33	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:CMTA	Clementia Pharmaceuticals Inc.
13/02/2019	08:24	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CMTA	Clementia Pharmaceuticals Inc.
12/02/2019	08:34	Edgar (US Regulatory)	Schedule 13g	NASDAQ:CMTA	Clementia Pharmaceuticals Inc.
11/02/2019	05:30	GlobeNewswire Inc.	Clementia Granted Rare Pediatric Disease Designation by FDA for Palovarotene for Fibrodysplasia Ossificans Progressiva	NASDAQ:CMTA	Clementia Pharmaceuticals Inc.
30/11/2018	08:00	GlobeNewswire Inc.	Clementia Announces the Departure of Chief Commercial Officer	NASDAQ:CMTA	Clementia Pharmaceuticals Inc.
21/11/2018	05:30	GlobeNewswire Inc.	Clementia to Present at the Evercore ISI HealthCONx Conference	NASDAQ:CMTA	Clementia Pharmaceuticals Inc.
07/11/2018	05:30	GlobeNewswire Inc.	Clementia Reports Third Quarter 2018 Operating Results and Pipeline Updates	NASDAQ:CMTA	Clementia Pharmaceuticals Inc.
30/10/2018	15:04	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:CMTA	Clementia Pharmaceuticals Inc.
29/10/2018	20:21	GlobeNewswire Inc.	Clementia Announces Pricing of Public Offering of Common Shares	NASDAQ:CMTA	Clementia Pharmaceuticals Inc.
29/10/2018	15:01	GlobeNewswire Inc.	Clementia Announces Proposed Public Offering of Common Shares	NASDAQ:CMTA	Clementia Pharmaceuticals Inc.